Clin Exp Reprod Med.
2017 Mar;44(1):1-7. 10.5653/cerm.2017.44.1.1.
Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan, Korea.
- 2Department of Obstetrics and Gynecology, Gangseo Mizmedi Hospital, Seoul, Korea.
- 3Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea.
- 4Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea.
- 5Department of Obstetrics and Gynecology, Gangnam Mizmedi Hospital, Seoul, Korea.
- 6Maria Fertility Hospital, Seoul, Korea.
- 7Department of Obstetrics and Gynecology, Bundang CHA Medical Center, CHA University, Seongnam, Korea.
- 8Seoul Rachel Fertility Center, Seoul, Korea.
- 9Department of Obstetrics and Gynecology, Konyang University College of Medicine, Daejeon, Korea. immune2015@naver.com sklee@kyuh.ac.kr
- KMID: 2408580
- DOI: http://doi.org/10.5653/cerm.2017.44.1.1
Abstract
- The task force of the Korean Society for Reproductive Immunology recommends intravenous immunoglobulin G treatment in women with reproductive failure, including recurrent pregnancy loss and/or repeated implantation failure, who show cellular immune factors such as abnormal natural killer cell levels, natural killer cell cytotoxicity, and/or type 1 T helper immunity.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Do family values and reproductive health knowledge influence reproductive health-promoting behaviors in married women? A cross-sectional survey
- Development of Reproductive Health Program and Identification of Effect for Married Women Immigrants
- Reproductive Health
- Reproductive Health Rights and Indicators
- Developing a deeper insight into reproductive biomarkers
